Skip to main content

Dengue Inpatient/Outpatient Dosing Study (CIR 332)

Outpatient study with a 3 night inpatient stay enrolling adults 18-55 years old.

The purpose of this trial is to study a medication to prevent dengue virus infection. We want to see if the medication will prevent you from becoming infected with Dengue virus.  In the future, we hope the medication will be used in travelers to help prevent them from getting dengue virus. The study (is):

  • 3 months long

  • 2-3 screening visits (about 2-3 hours each)

  • 1 three-night inpatient stay*

  • 1 dengue exposure visit (about 2-3 hours)

  • 16 outpatient visits

  • 1 full-day outpatient visit (12 hours)

Screening Date

No screening dates available.  Check back often for new screening opportunities!

Screening Location

CIR  at Bayview Medical Campus
301 Building, 4th floor
301 Mason Lord Drive
Baltimore, MD 21224

Study Period

3 months


up to $3850